Co-Diagnostics Past Earnings Performance

Past criteria checks 0/6

Co-Diagnostics's earnings have been declining at an average annual rate of -37.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been declining at an average rate of 4.9% per year.

Key information

-37.1%

Earnings growth rate

-33.4%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-4.9%
Return on equity-51.9%
Net Margin-411.2%
Next Earnings Update07 Nov 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Co-Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:C97 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 249-382023
31 Mar 247-392124
31 Dec 237-352123
30 Sep 235-432222
30 Jun 237-382221
31 Mar 2312-322119
31 Dec 2234-142217
30 Sep 2253152015
30 Jun 2278282216
31 Mar 22101402617
31 Dec 2198372515
30 Sep 21105422514
30 Jun 219646219
31 Mar 219351155
31 Dec 207542133
30 Sep 20482892
30 Jun 20261072
31 Mar 202-651
31 Dec 190-651
30 Sep 190-651
30 Jun 190-651
31 Mar 190-651
31 Dec 180-651
30 Sep 180-651
30 Jun 180-851
31 Mar 180-841
31 Dec 170-741
30 Sep 170-631
30 Jun 170-311
31 Mar 170-211
31 Dec 160-211
30 Sep 160-211
31 Dec 150-211

Quality Earnings: C97 is currently unprofitable.

Growing Profit Margin: C97 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: C97 is unprofitable, and losses have increased over the past 5 years at a rate of 37.1% per year.

Accelerating Growth: Unable to compare C97's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: C97 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: C97 has a negative Return on Equity (-51.89%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies